Mylan (MYL) Debuts EpiPen4Schools Program

Mylan Specialty L.P., the fully-integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: MYL), announced the EpiPen4Schools program. This effort offers four free EpiPen or EpiPen Jr (epinephrine) Auto-Injectors upon qualification, which includes having a valid prescription, to public and private kindergarten, elementary, middle and high schools in the U.S. The products will be available in the form of two EpiPen 2-Pak® cartons, two EpiPen Jr 2-Pak® cartons or one 2-Pak of each kind.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
• enVVeno Medical (NVNO) files $100M mixed shelf
• BIGG Digital Assets to rename as Surge Digital, consolidate shares